DermatomyositisSymptoms, Doctors, Treatments, Advances & More
Learn About Dermatomyositis
Dermatomyositis is a disease that involves muscle inflammation and a skin rash. Polymyositis is a similar inflammatory condition that also involves muscle weakness, swelling, tenderness, and tissue damage but no skin rash. Both are part of a larger group of diseases called myopathies, more specifically inflammatory myopathies.
The cause of dermatomyositis is unknown. Experts think it may be due to a viral infection of the muscles or a problem with the body's immune system. It may also occur in people who have cancer in the abdomen, lung, or other parts of the body.
Anyone can develop this condition. It most often occurs in children age 5 to 15 and adults age 40 to 60. It affects women more often than men.
Symptoms may include:
- Muscle weakness, stiffness, or soreness
- Purple color to the upper eyelids
- Purple-red skin rash
- Shortness of breath
- Difficulty swallowing
The muscle weakness may come on suddenly or develop slowly over weeks or months. You may have trouble raising your arms over your head, getting up from a sitting position, and climbing stairs.
The rash may appear on your face, knuckles, neck, shoulders, upper chest, and back.
The initial treatment is the use of corticosteroid medicines. The dose of medicine is slowly tapered off as muscle strength improves. This takes about 4 to 6 weeks. You may stay on a low dose of a corticosteroid medicine after that.
Medicines to suppress the immune system may be used to replace the corticosteroids. These medicines may include azathioprine, methotrexate or mycophenolate.
Treatments that may be tried when disease that remains active in spite of these medicines are:
- Intravenous gamma globulin
- Biologic medicines
When your muscles get stronger, your provider may tell you to slowly cut back on your doses. Many people with this condition must take a medicine called prednisone for the rest of their lives.
If a tumor is causing the condition, the muscle weakness and rash may get better when the tumor is removed.
Stanford University Medical Center
David Fiorentino is a Dermatologist practicing medicine in Redwood City, California. Dr. Fiorentino is rated as an Elite provider by MediFind in the treatment of Dermatomyositis. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Scleroderma, Systemic Sclerosis (SSc), and Calcinosis. Dr. Fiorentino is board certified in Board Certification: American Board Of Dermatology, Dermatology (2002).
Johns Hopkins Bayview Medical Center
Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is rated as an Elite provider by MediFind in the treatment of Dermatomyositis. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis. Dr. Christopher is board certified in American Board Of Internal Medicine.
Duke Children's Hospital & Health Center
I am a pediatric rheumatologist and immunologist, and I take care of children with immune and autoimmune problems, specifically juvenile arthritis, lupus, dermatomyositis, myositis fever disorders, and scleroderma. Many times we see children with all kinds of different complaints, and I work to investigate their symptoms and come up with a diagnosis and treatment plan. It is so gratifying to help kids feel better and get them back to their normal, healthy lives. The doctors here at Duke work as a robust and very specialized multidisciplinary team. When patients come here, they normally need to see multiple different specialists, and we have a unified center of care and come to them, instead of having them go to different appointments at different places. We partner with the family to define what care should happen and how to manage the patient. Dr. Reed is rated as an Elite provider by MediFind in the treatment of Dermatomyositis. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Juvenile Dermatomyositis, Myositis, Dermatomyositis, and Polymyositis. Dr. Reed is board certified in American Board Of Pediatrics, Pediatric Rheumatology.
It is important to be followed by a health care provider when you have dermatomyositis. Severe illness can lead to disability and can sometimes result in death.
Symptoms may go away completely in some people, such as children.
The condition may be fatal in adults due to:
- Severe muscle weakness
- Malnutrition
- Pneumonia
- Lung failure
The major causes of death with this condition are cancer and lung disease.
People with lung disease with the anti-MDA-5 antibody have a poor prognosis in spite of current treatment.
Complications may include:
- Lung disease
- Acute renal failure
- Cancer (malignancy)
- Inflammation of the heart
- Joint pain
Contact your provider if you have muscle weakness or other symptoms of this condition.
Summary: RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Objective: To see if omega-3 fatty acid supplements from fish oil, combined with a healthy diet, can help people with DM/JDM.
Published Date: January 28, 2025
Published By: Diane M. Horowitz, MD, Rheumatology and Internal Medicine, Northwell Health, Great Neck, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Dinulos JGH. Connective tissue diseases. In: Dinulos JGH, ed. Habif's Clinical Dermatology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 17.
Greenberg SA. Inflammatory myopathies. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 248.
Nagaraju K, Aggarwal R, Lundberg IE. Inflammatory diseases of muscle and other myopathies. In: Firestein GS, McInnes IB, Koretzky GA, Mikuls TR, Neogi T, O'Dell JR, eds. Firestein & Kelley's Textbook of Rheumatology. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 86.
National Organization for Rare Disorders website. Dermatomyositis. rarediseases.org/rare-diseases/dermatomyositis/. Updated May 4, 2018. Accessed February 27, 2025.